{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:54:54Z","timestamp":1791266094719,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100008347","name":"Bezmialem Vak\u0131f \u00dcniversitesi","doi-asserted-by":"publisher","award":["20240903"],"award-info":[{"award-number":["20240903"]}],"id":[{"id":"10.13039\/501100008347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"DOI":"10.1007\/s13760-026-03208-4","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:24:18Z","timestamp":1791264258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Shorter Leukocyte telomere length as a marker of biological aging in relapsing-remitting multiple sclerosis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3100-0866","authenticated-orcid":false,"given":"Ilker","family":"Karacan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9689-3111","authenticated-orcid":false,"given":"Seda","family":"Susgun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4166-9881","authenticated-orcid":false,"given":"Didem","family":"Savasci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7385-9479","authenticated-orcid":false,"given":"Begum","family":"Yigit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3580-7280","authenticated-orcid":false,"given":"Deniz","family":"Yozlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1173-1701","authenticated-orcid":false,"given":"Nur Damla","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2938-711X","authenticated-orcid":false,"given":"Omer Faruk","family":"Duzenli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5813-3397","authenticated-orcid":false,"given":"Aysegul","family":"Yabaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4512-8764","authenticated-orcid":false,"given":"Emrah","family":"Yucesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8103-0927","authenticated-orcid":false,"given":"Azize Esra Basar","family":"Gursoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"3208_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","volume":"403","author":"D Jakimovski","year":"2024","unstructured":"Jakimovski D, Bittner S, Zivadinov R et al (2024) Multiple sclerosis. Lancet 403:183\u2013202. https:\/\/doi.org\/10.1016\/S0140-6736(23)01473-3","journal-title":"Lancet"},{"key":"3208_CR2","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L et al (2020) Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler 26:1816\u20131821. https:\/\/doi.org\/10.1177\/1352458520970841","journal-title":"Mult Scler"},{"key":"3208_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s44197-025-00353-6","volume":"15","author":"G Khan","year":"2025","unstructured":"Khan G, Hashim MJ (2025) Epidemiology of multiple sclerosis: global, regional, national and sub-national-level estimates and future projections. J Epidemiol Glob Health 15:21. https:\/\/doi.org\/10.1007\/s44197-025-00353-6","journal-title":"J Epidemiol Glob Health"},{"key":"3208_CR4","doi-asserted-by":"publisher","first-page":"508","DOI":"10.5603\/PJNNS.a2020.0069","volume":"54","author":"W Brola","year":"2020","unstructured":"Brola W, Steinborn B (2020) Pediatric multiple sclerosis - current status of epidemiology, diagnosis and treatment. Neurol Neurochir Pol 54:508\u2013517. https:\/\/doi.org\/10.5603\/PJNNS.a2020.0069","journal-title":"Neurol Neurochir Pol"},{"key":"3208_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","volume":"13","author":"T Olsson","year":"2017","unstructured":"Olsson T, Barcellos LF, Alfredsson L (2017) Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol 13:25\u201336. https:\/\/doi.org\/10.1038\/nrneurol.2016.187","journal-title":"Nat Rev Neurol"},{"key":"3208_CR6","doi-asserted-by":"publisher","first-page":"a028951","DOI":"10.1101\/cshperspect.a028951","volume":"8","author":"NA Patsopoulos","year":"2018","unstructured":"Patsopoulos NA (2018) Genetics of multiple sclerosis: an overview and new directions. Cold Spring Harb Perspect Med 8:a028951. https:\/\/doi.org\/10.1101\/cshperspect.a028951","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3208_CR7","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1007\/s12035-021-02315-y","volume":"58","author":"M Hecker","year":"2021","unstructured":"Hecker M, Fitzner B, J\u00e4ger K et al (2021) Leukocyte telomere length in patients with multiple sclerosis and its association with clinical phenotypes. Mol Neurobiol 58:2886\u20132896. https:\/\/doi.org\/10.1007\/s12035-021-02315-y","journal-title":"Mol Neurobiol"},{"key":"3208_CR8","doi-asserted-by":"publisher","first-page":"1663526","DOI":"10.3389\/fimmu.2025.1663526","volume":"16","author":"A Iribarren-L\u00f3pez","year":"2025","unstructured":"Iribarren-L\u00f3pez A, Martins-Almeida L, Wells JK et al (2025) Aging-dependent immunological changes in multiple sclerosis. Front Immunol 16:1663526. https:\/\/doi.org\/10.3389\/fimmu.2025.1663526","journal-title":"Front Immunol"},{"key":"3208_CR9","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1177\/13524585231204122","volume":"29","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Atkinson J, Burd CE et al (2023) Biological aging in multiple sclerosis. Mult Scler 29:1701\u20131708. https:\/\/doi.org\/10.1177\/13524585231204122","journal-title":"Mult Scler"},{"key":"3208_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41576-019-0099-1","volume":"20","author":"JW Shay","year":"2019","unstructured":"Shay JW, Wright WE (2019) Telomeres and telomerase: three decades of progress. Nat Rev Genet 20:299\u2013309. https:\/\/doi.org\/10.1038\/s41576-019-0099-1","journal-title":"Nat Rev Genet"},{"key":"3208_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2019.02.003","volume":"51","author":"L Smith","year":"2019","unstructured":"Smith L, Luchini C, Demurtas J et al (2019) Telomere length and health outcomes: An umbrella review of systematic reviews and meta-analyses of observational studies. Ageing Res Rev 51:1\u201310. https:\/\/doi.org\/10.1016\/j.arr.2019.02.003","journal-title":"Ageing Res Rev"},{"key":"3208_CR12","doi-asserted-by":"publisher","first-page":"577187","DOI":"10.1016\/j.jneuroim.2020.577187","volume":"341","author":"R Habib","year":"2020","unstructured":"Habib R, Ocklenburg S, Hoffjan S, Haghikia A, Epplen JT, Arning L (2020) Association between shorter leukocyte telomeres and multiple sclerosis. J Neuroimmunol 341:577187. https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577187","journal-title":"J Neuroimmunol"},{"key":"3208_CR13","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3390\/ijms24020916","volume":"24","author":"GC L\u00f3pez-Armas","year":"2023","unstructured":"L\u00f3pez-Armas GC, Ramos-M\u00e1rquez ME, Navarro-Meza M et al (2023) Leukocyte telomere length predicts severe disability in relapsing-remitting multiple sclerosis and correlates with mitochondrial DNA copy number. Int J Mol Sci 24:916. https:\/\/doi.org\/10.3390\/ijms24020916","journal-title":"Int J Mol Sci"},{"key":"3208_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11010-014-2274-1","volume":"400","author":"J-Z Guan","year":"2015","unstructured":"Guan J-Z, Guan W-P, Maeda T et al (2015) Patients with multiple sclerosis show increased oxidative stress markers and somatic telomere length shortening. Mol Cell Biochem 400:183\u2013187. https:\/\/doi.org\/10.1007\/s11010-014-2274-1","journal-title":"Mol Cell Biochem"},{"key":"3208_CR15","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.3390\/jcm13092694","volume":"13","author":"M Duseikaite","year":"2024","unstructured":"Duseikaite M, Gedvilaite G, Mikuzis P et al (2024) Investigating the Relationship between telomere-related gene variants and leukocyte telomere length in optic neuritis patients. J Clin Med 13:2694. https:\/\/doi.org\/10.3390\/jcm13092694","journal-title":"J Clin Med"},{"key":"3208_CR16","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/gcc.22475","volume":"56","author":"YL Behrens","year":"2017","unstructured":"Behrens YL, Thomay K, Hagedorn M et al (2017) Comparison of different methods for telomere length measurement in whole blood and blood cell subsets: Recommendations for telomere length measurement in hematological diseases. Genes Chromosomes Cancer 56:700\u2013708. https:\/\/doi.org\/10.1002\/gcc.22475","journal-title":"Genes Chromosomes Cancer"},{"key":"3208_CR17","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.14336\/AD.2021.0106","volume":"12","author":"J B\u00fchring","year":"2021","unstructured":"B\u00fchring J, Hecker M, Fitzner B, Zettl UK (2021) Systematic review of studies on telomere length in patients with multiple sclerosis. Aging Dis 12:1272\u20131286. https:\/\/doi.org\/10.14336\/AD.2021.0106","journal-title":"Aging Dis"},{"key":"3208_CR18","doi-asserted-by":"publisher","first-page":"20160451","DOI":"10.1098\/rstb.2016.0451","volume":"373","author":"T-P Lai","year":"2018","unstructured":"Lai T-P, Wright WE, Shay JW (2018) Comparison of telomere length measurement methods. Philos Trans R Soc Lond B Biol Sci 373:20160451. https:\/\/doi.org\/10.1098\/rstb.2016.0451","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"3208_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"key":"3208_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/mps3020027","volume":"3","author":"MV Joglekar","year":"2020","unstructured":"Joglekar MV, Satoor SN, Wong WKM et al (2020) An optimised step-by-step protocol for measuring relative telomere length. Methods Protoc 3:27. https:\/\/doi.org\/10.3390\/mps3020027","journal-title":"Methods Protoc"},{"key":"3208_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10522-019-09843-0","volume":"21","author":"G Gedvilaite","year":"2020","unstructured":"Gedvilaite G, Vilkeviciute A, Kriauciuniene L et al (2020) The relationship between leukocyte telomere length and TERT, TRF1 single nucleotide polymorphisms in healthy people of different age groups. Biogerontology 21:57\u201367. https:\/\/doi.org\/10.1007\/s10522-019-09843-0","journal-title":"Biogerontology"},{"key":"3208_CR22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.21873\/cgp.20202","volume":"17","author":"P Vaiciulis","year":"2020","unstructured":"Vaiciulis P, Liutkeviciene R, Liutkevicius V, Vilkeviciute A, Gedvilaite G, Uloza V (2020) Association of relative leucocyte telomere length and gene single nucleotide polymorphisms (TERT, TRF1, TNKS2) in laryngeal squamous cell carcinoma. Cancer Genomics Proteom 17:431\u2013439. https:\/\/doi.org\/10.21873\/cgp.20202","journal-title":"Cancer Genomics Proteom"},{"key":"3208_CR23","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.3390\/cells11233847","volume":"11","author":"A Vilkeviciute","year":"2022","unstructured":"Vilkeviciute A, Gedvilaite G, Banevicius M, Kriauciuniene L, Zaliuniene D, Dobiliene O, Liutkeviciene R (2022) Relative leukocyte telomere length and genetic variants in telomere-related genes and serum levels role in age-related macular degeneration. Cells 11:3847. https:\/\/doi.org\/10.3390\/cells11233847","journal-title":"Cells"},{"key":"3208_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3390\/cancers16030643","volume":"16","author":"G Gedvilaite","year":"2024","unstructured":"Gedvilaite G, Kriauciuniene L, Tamasauskas A, Liutkeviciene R (2024) The influence of telomere-related gene variants, serum levels, and relative leukocyte telomere length in pituitary adenoma occurrence and recurrence. Cancers 16:643. https:\/\/doi.org\/10.3390\/cancers16030643","journal-title":"Cancers"},{"key":"3208_CR25","doi-asserted-by":"publisher","first-page":"103084","DOI":"10.1016\/j.msard.2021.103084","volume":"54","author":"AE Miner","year":"2021","unstructured":"Miner AE, Graves JS (2021) What telomeres teach us about MS. Mult Scler Relat Disord 54:103084. https:\/\/doi.org\/10.1016\/j.msard.2021.103084","journal-title":"Mult Scler Relat Disord"},{"key":"3208_CR26","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nri890","volume":"2","author":"RJ Hodes","year":"2002","unstructured":"Hodes RJ, Hathcock KS, Weng N (2002) Telomeres in T and B cells. Nat Rev Immunol 2:699\u2013706. https:\/\/doi.org\/10.1038\/nri890","journal-title":"Nat Rev Immunol"},{"key":"3208_CR27","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3389\/fimmu.2017.01078","volume":"8","author":"SS Jose","year":"2017","unstructured":"Jose SS, Bendickova K, Kepak T, Krenova Z, Fric J (2017) Chronic inflammation in immune aging: role of pattern recognition receptor crosstalk with the telomere complex? Front Immunol 8:1078. https:\/\/doi.org\/10.3389\/fimmu.2017.01078","journal-title":"Front Immunol"},{"key":"3208_CR28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/10408363.2018.1504274","volume":"55","author":"CL Fasching","year":"2018","unstructured":"Fasching CL (2018) Telomere length measurement as a clinical biomarker of aging and disease. Crit Rev Clin Lab Sci 55:443\u2013465. https:\/\/doi.org\/10.1080\/10408363.2018.1504274","journal-title":"Crit Rev Clin Lab Sci"},{"key":"3208_CR29","doi-asserted-by":"publisher","first-page":"105607","DOI":"10.1016\/j.msard.2024.105607","volume":"86","author":"M Zhong","year":"2024","unstructured":"Zhong M, Salberg S, Sampangi S, van der Walt A, Butzkueven H, Mychasiuk R, Jokubaitis V (2024) Leukocyte telomere length in multiple sclerosis: relationship between disability severity and pregnancy history. Mult Scler Relat Disord 86:105607. https:\/\/doi.org\/10.1016\/j.msard.2024.105607","journal-title":"Mult Scler Relat Disord"},{"key":"3208_CR30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jalz.2009.05.666","volume":"5","author":"JN Lukens","year":"2009","unstructured":"Lukens JN, Van Deerlin V, Clark CM et al (2009) Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer\u2019s disease. Alzheimers Dement 5:463\u2013469. https:\/\/doi.org\/10.1016\/j.jalz.2009.05.666","journal-title":"Alzheimers Dement"},{"key":"3208_CR31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s40266-020-00789-4","volume":"37","author":"S Paghera","year":"2020","unstructured":"Paghera S, Sottini A, Previcini V, Capra R, Imberti L (2020) Age-related lymphocyte output during disease-modifying therapies for multiple sclerosis. Drugs Aging 37:739\u2013746. https:\/\/doi.org\/10.1007\/s40266-020-00789-4","journal-title":"Drugs Aging"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03208-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-026-03208-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03208-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:24:19Z","timestamp":1791264259000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-026-03208-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":31,"alternative-id":["3208"],"URL":"https:\/\/doi.org\/10.1007\/s13760-026-03208-4","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"21 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Bezmialem Vakif University, Clinical Research Ethics Committee (Date and number: 09.09.2024-E.164564) and was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":".","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}]}}